Vistagen begins using updated corporate presentation on January 8, 2024

Vistagen Therapeutics, Inc.

New corporate presentation adopted by Vistagen Therapeutics on Jan 8, 2024.
Presentation attached as Exhibit 99.1; no financial or pipeline details provided in the filing.
Item 7.01 disclosure; information is furnished, not filed, under SEC rules.

item 7.01 item 9.01

Vistagen Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-24-000902

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.